CIDI at the Union 2023

Post Date: 

CIDI was in Paris for The Union Conference on Lung Health 2023! Check out what CIDI faculty and Johns Hopkins India Partners spoke about at the sessions listed!

Wednesday, November 15, 2023
Session times noted in Central European Time

15:00-16:30  |  Location: 251

  • OA04 Clinical and epidemiologic aspects of post-TB lung health: Oral Abstract Session
    • Mandar Paradkar: Speaker: OA04-224-15 Incidence and determinants of sub-clinical recurrence of TB among cured patients with pulmonary TB in India
    • Akshay Gupte: Speaker: OA04-226-15 Development and validation of a simple, point-of-care, case-finding approach for post-TB lung disease

15:00-16:30  |  Location: 241

  • SP07 Improving treatment for persons with tuberculosis and substance use: Symposium
    • Geetanjali Chander: Speaker: Hybrid trial for alcohol reduction among people with TB and HIV/TB in India (HATHI): Intervention adaptation and implementation

Thursday, November 16, 2023
Session times noted in Central European Time

18:30-2:00  |  Location: 242A

  • SS10 BENEFIT Kids: Better Evidence and Formulations to Improved Multidrug-Resistant Tuberculosis Treatment in Children: Satellite Session
    • Nishi Suryavanshi: Speaker: CATALYST: Acceptability of novel moxifloxacin and clofazimine formulations in children with MDR-TB: sociobehavioural data from South Africa, the Philippines and India

16:45-18:15  |  Location: 242A

  • OA28 Into the unknown: gender, TB and pregnancy: Oral Abstract Session
    • Jyoti Mathad, Chair
    • Mallika Alexander, Speaker: OA28-421-16 High prevalence of antepartum and postpartum depressive symptoms and their association with active TB: Findings from a prospective longitudinal cohort of pregnant and postpartum Indian women

Saturday, November 18
Session times noted in Central European Time

  • 08:30-10:00  |  Location: 243
    • SOA22 Drug sensitive TB: Treatment and Care: Short Oral Abstract Session
      • Nishi Suryavanshi: Chair | Speaker: SOA22-971-18 The socio-economic impact of the COVID-19 pandemic in households having children with rifampicin-resistant TB: A qualitative study from South Africa, India and the Philippines
  • 10:15-11:45  |  Location: 202/203
    • SP49 Into the unknown: Drug-resistant TB in pregnancy: Symposium
    • Jyoti Mathad: Chair
    • Mallika Alexander: Chair | Speaker: A case-based discussion of drug-resistant TB in pregnancy
  • 13:15-14:45  |  Location: 242A
    • OA68 Diagnosis for TB Diagnosis: Oral Abstract Session
      • Sanjay Gaikwad: Speaker: OA68-739-18 Early microbiologic surrogate markers of pulmonary TB treatment outcomes
  • 13:15 - 14:45  |  Location: 241
    • OA69 TB stigma, discrimination and equity: Oral Abstract Session
      • Abhay Kadam: Speaker: OA69-745-18 TB-related stigma among TB survivors and their household contacts: an overlooked but major barrier to TB elimination in India
      • Gauri Dhumal: Speaker: OA69-749-18 Creating-A-Hope: most preferred psycho-social intervention among adolescents and young adults with multidrug-resistant TB to improve programmatic outcomes in Pune, India
  • 13:15 - 14:00  |  Location: Foyer Bleu Paris
    • CC-24 A new approach to accelerate research and close gaps in access to new TB drugs for children: Community Connect Session
    • Mandar Paradkar: Chair


  • EP14 TB Infection and TPT: E-Poster
    • Aarti Kinikar: Presenter: EP14-1131-16 Shorter TB preventive therapy among children living with HIV and child household contacts of pulmonary TB patients: a 3HP demonstration project in Pune, India